We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

135 hedge funds and large institutions have $151M invested in Perspective Therapeutics in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 49 increasing their positions, 31 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 31

50% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 24

6% more funds holding

Funds holding: 127 → 135 (+8)

2.92% less ownership

Funds ownership: 72.82% → 69.91% (-2.9%)

37% less call options, than puts

Call options by funds: $331K | Put options by funds: $527K

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

77% less capital invested

Capital invested by funds: $655M → $151M (-$504M)

Holders
135
Holders Change
+8
Holders Change %
+6.3%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
36
Increased
49
Reduced
31
Closed
24
Calls
$331K
Puts
$527K
Net Calls
-$196K
Net Calls Change
+$1.15M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$36.9M
2
Millennium Management
Millennium Management
New York
+$10.6M
3
PA
Perceptive Advisors
New York
+$9.72M
4
OCA
Octagon Capital Advisors
New York
+$7.21M
5
Morgan Stanley
Morgan Stanley
New York
+$7.01M

Top Sellers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
-$44.7M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$39M
3
PBA
Paradigm Biocapital Advisors
New York
-$12.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10M
5
State Street
State Street
Massachusetts
-$8.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
JFA
126
JNBA Financial Advisors
Minnesota
$1.59K – – –
SCM
127
Sterling Capital Management
North Carolina
$1.25K +$2.65K +324 +484%
FFA
128
Farther Finance Advisors
California
$1.11K – – –
TWC
129
TD Waterhouse Canada
Ontario, Canada
$636 – – –
VWM
130
Vermillion Wealth Management
Minnesota
$619 +$1.58K +194 New
CIAM
131
Caitong International Asset Management
Hong Kong
$367 +$939 +115 New
GI
132
GAMMA Investing
California
$204 +$376 +46 +256%
Osaic Holdings
133
Osaic Holdings
Arizona
$143 – – –
SS
134
SBI Securities
Japan
$3 +$8 +1 New
CC
135
Commodore Capital
New York
– -$44.7M -3,350,000 Closed
PBA
136
Paradigm Biocapital Advisors
New York
– -$12.3M -919,692 Closed
Adage Capital Partners
137
Adage Capital Partners
Massachusetts
– -$10M -750,000 Closed
ECM
138
ExodusPoint Capital Management
New York
– -$7.76M -581,614 Closed
ABG
139
Ally Bridge Group
New York
– -$4.56M -341,739 Closed
SC
140
Stempoint Capital
New York
– -$3.18M -238,084 Closed
SCM
141
Silverarc Capital Management
Massachusetts
– -$2.24M -167,986 Closed
SI
142
Sofinnova Investments
California
– -$1.61M -120,632 Closed
SCM
143
Sandler Capital Management
New York
– -$1.37M -102,806 Closed
Rafferty Asset Management
144
Rafferty Asset Management
New York
– -$1.35M -101,138 Closed
ACM
145
Atika Capital Management
New York
– -$1.34M -100,000 Closed
OCM
146
Osterweis Capital Management
California
– -$1.22M -91,293 Closed
AA
147
AlphaCentric Advisors
Puerto Rico
– -$1.07M -80,000 Closed
LP
148
LMR Partners
United Kingdom
– -$401K -30,000 Closed
RAG
149
RIA Advisory Group
Iowa
– -$342K -25,620 Closed
SAM
150
Sectoral Asset Management
Quebec, Canada
– -$272K -20,400 Closed
3 4 5
6
7

CATX Hedge Fund Activity: Q4 2024 in Review

135 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2024, worth a combined $151M — down 77% from $655M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CATX positions and 24 closed out — a net gain of 12 holders — while 49 added to existing stakes and 31 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $36.9M. The largest seller was Commodore Capital, exiting entirely with an estimated $44.7M sold.

  • 135 institutional investors held Perspective Therapeutics (CATX) as of Q4 2024, up from 127 in Q3 2024.
  • Funds reported $151M of Perspective Therapeutics stock for Q4 2024, down 77% quarter-over-quarter.
  • 36 funds opened new Perspective Therapeutics positions in Q4 2024 and 24 closed out, a net change of +12 holders.
  • The largest Perspective Therapeutics buyer in Q4 2024 was Fidelity Investments, an estimated $36.9M added.
  • The largest Perspective Therapeutics seller in Q4 2024 was Commodore Capital, an estimated $44.7M sold.

Based on aggregated 13F filings for Q4 2024.